Bora Lim
Director - Translational Research The University of Texas MD Anderson Cancer Center.
Seminars
Monday 18th May 2026
Introducing Myriad’s Ultra-Sensitive Tumor Informed MRD Assay
4:00 pm
- 6:00 pm
Join us for a hosted learning and networking engager in partnership with Myriad Genetics
Join this deep-dive session to understand how ultra-sensitive, tumor-informed MRD testing is being applied across real clinical and development settings. Hear how leading experts are translating MRD data into actionable decisions across patient management, trial design, and therapeutic development. Walk away with a clear view of where MRD delivers value today and how to apply it across your own programs.
Register your interest* to attend
*Attendance subject to availability and partner approval. For T&Cs please visit website.
Tuesday 19th May 2026
A Phase II Trial of Adjuvant PD-1 Blockade with Endocrine Therapy in Hormone Receptor Positive Inflammatory Breast Cancer: Circulating Biomarkers (ctDNA) & Molecular Correlates of Clinical Outcomes
11:30 am
